YAP1 has been shown to be hyperactivated or overexpressed in pancreatic tumor samples [13,14], and it functions as a critical transcriptional effector downstream of the oncogenic KRAS-MAPK (mitogen-activated protein kinase) pathway to promote neoplastic progression to pancreatic ductal adenocarcinoma in mice [15]. Here, KRAS is linked to pancreatic neoplasm.